DIRECTORY
BIOTECH
Pharmaclient

   

Quick Click ! Monthly news Home-Site Menu-Site Contactexpress Faqs Legends Companies Events Environment Memories Home-Biotech

Abcys | AB Science | Adocia | Advicenne Pharma | Affichem | Agate Bioservices | Aisa Therapeutics | Alfact Innovation | Alizé Pharma | Ambiotis | Anaconda Pharma | Aptys Pharmaceuticals | Ariana Pharmaceuticals | Aterovax | Atlantic Bone Screen | Aureus Sciences | B Cell Design | BioAlliance Pharma | Biocortech | BioCydex | Biométhodes | Biom'up | BioProtein Technologies | BioQuanta | BioSystems International | BMSystems (Bio-Modeling) | Carmat | Cellectis | Cellial Technologies | CellProthera | CellVax | Cerenis Therapeutics | CliniGenetics | Covalab | Cytheris | Cytoo | DBV Technologies | Diaxonhit | DNA Therapeutics | Domain Therapeutics | Dynabio | Edelris | Endotis Pharma | Epixis | ERYtech Pharma | Eye Tech Care | Flamel Technologies | Fluofarma | GemacBio | Genepep | Genewave | Genfit | Genomic Vision | GenoSafe | GenoScience Pharma | Genoscreen | GenOway | Genticel | GTP Technology | Helios Biosciences | Hemarina | Hybrigenics | Hyphen BioMed | Imagene | ImmunId | Immutep | Imstar | In-Cell-Art | Indicia Biotechnology | InGen Biosciences | Innate Pharma | InnaVirVax | Innovative Health Diagnostics | IntegraGen | Ipsogen | I-Stem | Karcinolys | Keosys | MABlife | Magnisense | Mapreg | Mauna Kea Technologies | Medesis Pharma | Mellitech | Metabolys | MilleGen | Murigenetics | NanoBiotix | Neorphys | Neovacs | Netris-Pharma | Neuronax | NewVectys | NicOx | Nokad | Nosopharm | NovAliX | NovoCIB | Novotec | Obe Therapy | Oligovax | Oncodesign | OriBase Pharma | Oroxcell | Oxincell | Palumed | PharmaLeads | Pharnext | PhenoPro | Pherecydes Pharma | PolyIntell | Proteogenix | Protexel | PX'Therapeutics | Quantum Genomics | Rhenovia Pharma | ScarCell Therapeutics | Sisène Biotechnologies | Skuld-Tech | Stentys | Synapcell | Synprosis | Tc Land Expression | Theraclion | Theradiag | Theralpha | TheraVectys | Transgene | Trophos | TxCell | UROsphere | Vaxon Biotech | Vectalys | Vivalis | XenTech |

* BIOPROTEIN TECHNOLOGIES *


 

1998 - IDF
Jouy-en-Josas
(near Paris)
www.bioprotein.com

 

Contract, Manufacturing
Key words: Therapeutic proteins, Gene expression, Transgenic rabbits
Mission: to provide third parties with production of recombinant therapeutic proteins and vaccines in the milk of transgenic rabbits, as a fully integrated service from gene expression to industrial production of purified proteins and vaccines
Clients: Pharma industry, Research labs, Biotechs
contact@bioprotein.com

Age: 18 year(s)

 

 

Identity
TYPE/MANAGEMENT/INVESTORSFINANCES/STATUS

Personal venture |
Managing Dir.-CEO: Lignel (Jean)
Sc.Dir.-CSO: Ripoll (Pierre-Jean) [Ph.D., ex-Aventis, Biogemma]
Fin.Dir.-CFO:
BusDev: Fouassier (Alexandre) [Eng. INRA, M.Sc. biochemistry, also COO]
Financers (Hist.): Société Générale A.M., Gilde, Creagro, Iwic, Anvar

Turnover (M€) : 0.085 (2009), 0.020 (2008), 0.009 (2007), 0.03 (2006)
Total funding (M€) : 11.0
Last funding (M€) : 0.5
Focus : Multiple
Position : Preclin
Company confirm : none

 

History
DATEMILESTONETYPETIME
2010 .05 3rd round-financing : 0.52 M€, by existing investors RFINC [11 years]
2009 .09 Set-up of Transgenic Rabbit Models (TRM), a subsidiary servicing company dedicated to the development and supply of genetically modified rabbit models (www.transgenic-rabbit-models.com) ORGC [11 years]
2006 .12 Set-up of Bioprotein Transgenics, a subsidiary ORGC [8 years]
2006 .03 Company move from Paris to Jouy-en-Josas (IDF), within INRA premices, in order to join own existing laboratories ORGL [7 years]
2006 .10 Nomination : Jean Lignel as CEO (replacing CEO and founder, Marc Le Bozec) ORGN [8 years]
2003 .04 2nd round-financing : 1.5 M€, by previous investors RFINB [4 years]
2001 .05 1st round-financing : 8.0 M€, by Société Générale A.M., Gilde, Creagro, Iwic, Anvar RFINA [2 years]
1998 .06 Company founded by 3 INRA scientists involved in transgenic animal and cloning research, Louis-Marie Houdebine, Jean-Paul Renard and Bernard Jégou, and an experienced manager from the business consultancy world, Marc Le Bozec ORGF [0 year]

Actualisation / Updating: 3-May-2011

   


Pharmaclient est le site-conseil de la Valorisation Client en Pharma...
Pour toute Mission, Inscription à la Pharmagalerie, Insertion dans la base Biotech, ou Question: CONTACT



© J.H. Huber, Pharmaclient 2001-2017. Pour retourner à la page d'accueil Biotech: BIENVENUE !       Haut de page : légende